Katrien Remaut
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 67
- Advanced biosensing and bioanalysis techniques 50
- DNA and Nucleic Acid Chemistry 14
- Retinal Development and Disorders 14
- Biomaterials 25
- Nanoparticle-Based Drug Delivery 21
- Co-authors
- Stefaan C. De Smedt (89 shared papers)Kevin Braeckmans (57 shared papers)Jo Demeester (14 shared papers)Karen Peynshaert (24 shared papers)Joke Devoldere (12 shared papers)Niek N. Sanders (17 shared papers)Thomas Martens (6 shared papers)B. Lucas (13 shared papers)
- Journals
- Journal of Controlled Release (30 papers)Molecular Pharmaceutics (6 papers)European Journal of Pharmaceutics and Biopharmaceutics (6 papers)Advanced Drug Delivery Reviews (5 papers)Pharmaceutics (4 papers)
- Partner nations
- BelgiumNetherlandsFrance
In The Last Decade
Katrien Remaut
117 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 149
- Biomaterials 909
- Pharmaceutical Science 329
- Molecular Biology 2.5k
- Ophthalmology 279
- Biophysics 173
Countries citing papers authored by Katrien Remaut
This map shows the geographic impact of Katrien Remaut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrien Remaut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrien Remaut more than expected).
Fields of papers citing papers by Katrien Remaut
This network shows the impact of papers produced by Katrien Remaut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrien Remaut. The network helps show where Katrien Remaut may publish in the future.
Co-authors
The 25 scholars most cited alongside Katrien Remaut, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 294 | |
| 2 | 2018 | 182 | |
| 3 | 2020 | 134 | |
| 4 | 2015 | 126 | |
| 5 | 2006 | 117 | |
| 6 | 2021 | 104 | |
| 7 | 2017 | 99 | |
| 8 | 2015 | 93 | |
| 9 | 2006 | 91 | |
| 10 | 2020 | 88 | |
| 11 | 2016 | 88 | |
| 12 | 2007 | 80 | |
| 13 | 2011 | 76 | |
| 14 | 2013 | 76 | |
| 15 | 2023 | 75 | |
| 16 | 2020 | 70 | |
| 17 | 2019 | 68 | |
| 18 | 2007 | 66 | |
| 19 | 2010 | 66 | |
| 20 | 2014 | 64 |
About Katrien Remaut
Katrien Remaut is a scholar working on Molecular Biology, Biomaterials, Radiology, Nuclear Medicine and Imaging, Surgery and Ophthalmology, having authored 123 papers that have together received 4.3k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (67 papers), Advanced biosensing and bioanalysis techniques (50 papers), Nanoparticle-Based Drug Delivery (21 papers), DNA and Nucleic Acid Chemistry (14 papers), Retinal Development and Disorders (14 papers), Retinal and Macular Surgery (13 papers), Virus-based gene therapy research (12 papers) and Intraperitoneal and Appendiceal Malignancies (11 papers). The work is most often cited by research in Biomaterials (909 citations), Pharmaceutical Science (329 citations), Molecular Biology (2.5k citations), Ophthalmology (279 citations) and Biophysics (173 citations). Katrien Remaut has collaborated with scholars based in Belgium, Netherlands and France. Frequent co-authors include Stefaan C. De Smedt, Kevin Braeckmans, Jo Demeester, Karen Peynshaert, Joke Devoldere, Niek N. Sanders, Thomas Martens, B. Lucas, J. Demeester and Wim Ceelen. Their work appears in journals such as Journal of Controlled Release, Molecular Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics, Advanced Drug Delivery Reviews and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.